» Authors » A Harfstrand

A Harfstrand

Explore the profile of A Harfstrand including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 91
Citations 700
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fuxe K, Cintra A, Agnati L, Harfstrand A, Goldstein M
Neurochem Int . 2010 May; 13(2):179-97. PMID: 20501287
The relationship between tyrosine hydroxylase (TH), dopamine (DA) and cyclic AMP-regulated phosphoprotein-32 (DARPP-32) immunoreactive (IR) neuronal structures and D1 receptor antagonist binding sites has been analysed in various brain regions...
2.
Fuxe K, Agnati L, Andersson K, Cintra A, Harfstrand A, Zoli M, et al.
Neurochem Int . 2010 May; 13(2):165-78. PMID: 20501286
D1 receptor mechanisms in the median eminence have been studied by means of immunocytochemistry using antisera against dopamine and cyclic AMP-regulated phosphoprotein-32 (DARPP-32) and tyrosine hydroxylase (TH) and by autoradiography...
3.
Andersson K, Fuxe K, Eneroth P, Harfstrand A, Agnati L
Neurochem Int . 2010 May; 13(2):159-63. PMID: 20501285
Nicotine (4 x 2 mg/kg, i.p.) was given every 30 min for 2 h to male rats. Some rats were pretreated with the D1 dopamine (DA) receptor antagonist SCH 23390...
4.
Ruggeri M, Ungerstedt U, Agnati L, Mutt V, Harfstrand A, Fuxe K
Neurochem Int . 2010 May; 10(4):509-20. PMID: 20501123
By means of intracerebral microdialysis effects of cholecystokinin peptides and neurotensin administered via the microdialysis probe have been studied on dopamine release and metabolism in the nucleus accumbens and neostriatum...
5.
Harfstrand A, Fuxe K, Agnati L, Kitayama I, Cintra A, Janson A, et al.
Neurochem Int . 2010 May; 10(4):481-94. PMID: 20501121
(1) In the present study the occlusion method was employed to evaluate the overall coexistence of neuropeptide Y and phenylethanolamine-N-methyl transferase, neuropeptide Y and tyrosine hydroxylase as well as cholecystokinin...
6.
Fuxe K, Andersson K, Harfstrand A, Agnati L, Eneroth P, Janson A, et al.
Neurochem Int . 2010 May; 9(1):155-70. PMID: 20493113
Somatostatin/catecholamine as well as growth hormone releasing factor/catecholamine interactions have been characterized in the hypothalamus and the preoptic area using morphometrical and quantitative histofluorimetrical analyses. The combined results of the...
7.
Cintra A, Fuxe K, Harfstrand A, Agnati L, Miller L, Greene J, et al.
Neurochem Int . 2010 May; 8(4):587-95. PMID: 20493093
By means of indirect immunoperoxidase procedures using the biotin- avidin method in combination with monoclonal antibodies to the human estrogen receptor it has been possible to map out distinct populations...
8.
Harfstrand A, Fuxe K, Agnati L, Eneroth P, Zini I, Zoli M, et al.
Neurochem Int . 2010 May; 8(3):355-76. PMID: 20493065
Neuropeptide Y-catecholamine interactions have been analyzed within the hypothalamus and in the forebrain of male rats by means of immunocytochemistry in combination with morphometry, quantitative histofluorimetry on catecholamine fluorescence in...
9.
Fuxe K, Agnati L, Andersson K, Eneroth P, Harfstrand A, Goldstein M, et al.
Neurochem Int . 2010 May; 6(6):737-50. PMID: 20488102
Neurotensin (NT)-catecholamine (CA) interactions have been characterized at the pre- and post synaptic level in the hypothalamus and the forebrain by a combined morphometrical, receptor autoradiographical, biochemical and quantitative microfluorimetrical...
10.
Nishi O, Nishi K, Imanishi M, Mano C, Yamada Y, Tada Y, et al.
J Cataract Refract Surg . 1996 Jan; 22 Suppl 1:859-62. PMID: 9279685
Purpose: To evaluate whether heparin surface modification reduces prostaglandin E2 (PGE2) synthesis by lens epithelial cells (LECs) after intraocular lens (IOL) implantation. Setting: Nishi Eye Hospital, Jinshikai Medical Foundation, Osaka,...